Overview
Portfolio
More
Redhill Capital
Portfolio
15+
Employees
N/A
Founded
N/A
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedFund details
Funds
Redhill Capital Medical RMB Fund I
Vintage 2019
Redhill Technology Innovation Venture Fund III
Vintage 2023
Sources
Redhill Capital
Portfolio
15+
Employees
N/A
Founded
N/A
AUM
N/A
Funds
Redhill Capital Medical RMB Fund I · Vintage 2019
Redhill Technology Innovation Venture Fund III · Vintage 2023
Showing 15 of 15 matched portfolio companies
AgiBot develops and manufactures humanoid robots and embodied intelligence systems designed for various applications, including interactive services and flexible manufacturing. Their technology enhances productivity by automating tasks in diverse environments, addressing labor shortages and operational inefficiencies.
ANTE is a social fitness platform that enables users to engage in real-life challenges with friends and family, fostering accountability and motivation in building healthy habits. By leveraging competitive elements, ANTE addresses the difficulty of maintaining consistent wellness routines through collaborative goal-setting and progress tracking.
The startup develops targeted therapies for cancer treatment through drug discovery focused on tumor immunology. By enhancing the immune response against tumors, the company aims to improve the quality of life for cancer patients.
Funding: $20.0M
Rough estimate of the amount of funding raised
Funding: $20.0M
Rough estimate of the amount of funding raised
<name>Hi</name>
<description>Hi provides a licensed crypto‑fiat neobank platform that enables users to trade over 100 cryptocurrencies alongside traditional fiat currencies. The app combines trading, yield‑earning savings accounts, and payment functionality in a single mobile interface. Users can set flexible crypto savings goals and withdraw funds at any
Founded 2020
1000+
Approximate amount of employees
Funding: $30.0M
Rough estimate of the amount of funding raised
Funding: $30.0M
Rough estimate of the amount of funding raised
IAN Intelligent Agent Network utilizes a decentralized Layer 2 infrastructure to integrate multiple AI agents, providing unbiased insights and enhancing trust through its Trust Engine, which scores Focus and Consistency. This approach addresses the issues of disinformation and bias in AI models, ensuring secure and transparent decision-making for businesses and individuals.
IDVerse provides a fully automated identity verification solution that uses facial recognition and machine learning to authenticate users in real-time across 220 countries, achieving 99.99% accuracy. The platform addresses the challenges of identity fraud and compliance by enabling secure onboarding and KYC processes without human intervention.
Funding: $30.0M
Rough estimate of the amount of funding raised
Funding: $30.0M
Rough estimate of the amount of funding raised
Lia is a sales platform providing payment solutions designed to increase conversion rates for digital schools and infoproduct sellers. The platform facilitates sales through multiple payment methods, including installment options for Pix and boleto, while offering automated risk analysis and 24/7 anti-fraud protection. Lia also manages the entire collections process to reduce partner delinquency and ensure predictable revenue streams.
Funding: $5.8M
Rough estimate of the amount of funding raised
Funding: $5.8M
Rough estimate of the amount of funding raised
Ling Technology is an AI technology company focused on developing solutions for the AI Internet era. The company addresses the challenges of data integration and analysis across global platforms, enhancing operational efficiency for businesses in a rapidly evolving digital landscape.
This company provides MESH Auditor, an operating system for mortgage loan servicing compliance that automatically measures loan portfolios against over 1,000 regulations daily. The platform encodes regulatory requirements into code, enabling daily portfolio coverage and targeted file audits to significantly reduce compliance costs. MESH helps servicers track performance, prioritize high-risk loans, and reduce exposure to regulatory fines.
The startup operates a molecular imaging platform that utilizes non-invasive radiopharmaceutical imaging technology to detect early-stage colorectal, esophageal, and lung adenocarcinoma. This technology enables healthcare providers to make precise diagnoses and tailor cancer treatment plans, improving patient outcomes and care efficiency.
10+
200+Approximate amount of employees
Funding: $2.5M
Rough estimate of the amount of funding raised
Funding: $2.5M
Rough estimate of the amount of funding raised
Vistel builds AI‑enabled ophthalmic hardware that delivers portable, non‑mydriatic fundus imaging and rapid vision screening for low‑resource settings. Their RC350 and RX350 cameras capture 4K–8K retinal images and upload them to an on‑device AI platform for instant diagnostic reports, while the VS550 handheld screener provides automated refractive assessments with PDF output and DICOM integration. These tools enable community health centers, primary‑care clinics, and mobile health programs to perform comprehensive eye examinations without specialist operators.
Westlake Omics develops AI-powered proteomics technology that enhances the precision of tumor diagnostics through quantitative and spatial proteomics methods. By providing reliable diagnostic tools, the company aims to improve patient outcomes in clinical settings by enabling accurate tumor characterization.
The startup develops financial technology that employs artificial intelligence and machine learning to create neural networks tailored for the financial services sector. This technology enhances efficiency by automating credit risk assessment, market risk analysis, compliance checks, and operational processes, reducing reliance on manual tasks and traditional automation tools.
Founded 2015
1000+
Approximate amount of employees
Funding: $370.0K
Rough estimate of the amount of funding raised
Funding: $370.0K
Rough estimate of the amount of funding raised
Shargetech develops and manufactures gallium nitride (GaN) chargers that provide faster charging times and improved energy efficiency for consumer electronics. By utilizing GaN technology, these chargers reduce heat generation and size, addressing the demand for compact and high-performance charging solutions.
The startup develops TCR gene therapy solutions that provide personalized immunotherapy for cancer patients by engineering T-cell receptors to target specific tumor antigens. This approach enhances treatment efficacy and minimizes side effects compared to traditional therapies.